Precision Medicine News and Updates | Precision Medicine Online
Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
Precision Oncology News - Precision Medicine Online
Nov 5, 2024 · Find the latest news on biomarker-guided cancer care, including clinical trials, approvals, partnerships, and research. Stay updated on the developments and trends in precision oncology with articles, interviews, and analysis.
Breaking News - Precision Medicine Online
Nov 4, 2024 · Get the latest news on precision medicine research, development, and commercialization. Find out about new trials, approvals, acquisitions, and innovations in the field.
Precision Medicine Diagnostics
Oct 10, 2024 · News and analysis on diagnostic technologies and applications for precision medicine from Precision Medicine Online.
Disease Research & Diagnostics News | Precision Medicine Online
News and analysis on disease research and diagnostics from Precision Medicine Online.
Genomics Technology, Tools & Methods - Precision Medicine Online
Oct 29, 2024 · The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics from Precision Medicine Online.
Molecular Diagnostics News | Precision Medicine Online
Oct 15, 2024 · News on lab-developed tests, emerging diagnostic technologies and tests from Precision Medicine Online.
Autoimmune Disease Research News - Precision Medicine Online
Jul 11, 2024 · News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more from Precision Medicine Online.
Business & Financial News | Precision Medicine Online
Oct 28, 2024 · Read breaking news on Precision Oncology business, policy & funding. Find updates in the life science and diagnostics business world from Precision Medicine Online.
Precision Oncology Precision Oncology News - Precision Medicine …
Oct 7, 2024 · The test is approved for patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.